Developing and adapting a mobile health exercise intervention for older patients with myeloid neoplasms: A qualitative study. Issue 6 (July 2021)

• Record Type: Journal Article
• Authors: Loh, Kah Poh; Sanapala, Chandrika; Di Giovanni, Grace; Klepin, Heidi D.; Janelsins, Michelle; Schnall, Rebecca; Culakova, Eva; Vertino, Paula; Susiarjo, Martha; Mendler, Jason H.; Liesveld, Jane L.; Lin, Po-Ju; Dunne, Richard F.; Kleckner, Ian; Mustian, Karen; Mohile, Supriya G.
• Is Part Of: Journal of geriatric oncology. Volume 12:Issue 6(2021)
• Page Start: 909
• Page End: 914
• Publication Date: 2021-07
• Subjects: Mobile health -- Exercise intervention -- Geriatric hematology -- Myeloid neoplasms; Geriatric oncology -- Periodicals; Neoplasms -- Periodicals; Aged -- Periodicals; Geriatric oncology; Electronic journals; Periodicals; 618.976994005
• DOI: 10.1016/j.jgo.2021.02.023
• Languages: English
• ISSNs: 1879-4068

Abstract

Abstract: Introduction: Older patients with myeloid neoplasms (MN) receiving outpatient chemotherapy are at risk of experiencing treatment-related toxicities such as functional decline. A mobile health (mHealth) exercise intervention may ameliorate these toxicities. This qualitative study aimed to inform the design of a mHealth exercise intervention for this population. Methods: This was a qualitative study of thirteen patients aged ≥60 years receiving hypomethylating agents for MN. EXCAP©® is a home-based walking and progressive resistance exercise program. We combined EXCAP©® with a mobile app; the combination (GO-EXCAP Mobile App) has not been previously tested. A brief verbal description about the intervention was provided to the participants but they did not perform it. Participants were interviewed and inductive thematic analysis was used to analyze the data. Results: Mean age was 71.6 (SD 8.5). Three themes were identified: 1) Perceptions of the intervention feasibility, 2) Ways to leverage the app to deliver the exercise intervention, and 3) Personalized exercise goals. Walking and resistance exercises were perceived to be feasible. Patients were comfortable initiating the intervention in cycle 2 of chemotherapy, with exercise increments occurring from week 2–4 of the cycle. Ways to leverage the app to deliver EXCAP©® include 1) Video feature for exercise demonstration and interactions, and 2) Exercise data and symptom surveys to be communicated to the exercise physiologist and primary oncology team. Preservation of existing function and activity was an important goal to participants. Conclusions: Our findings provide insights about the preferences of older adults with MN for a mHealth exercise intervention.